1.45
price up icon1.40%   0.02
after-market 시간 외 거래: 1.45
loading
전일 마감가:
$1.43
열려 있는:
$1.42
하루 거래량:
31,794
Relative Volume:
0.43
시가총액:
$7.36M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
-36.96%
6개월 성능:
-71.23%
1년 성능:
-91.21%
1일 변동 폭
Value
$1.36
$1.47
1주일 범위
Value
$1.36
$1.62
52주 변동 폭
Value
$1.36
$19.44

Traws Pharma Inc Stock (TRAW) Company Profile

Name
명칭
Traws Pharma Inc
Name
전화
267-759-3680
Name
주소
12 PENNS TRAIL, NEWTOWN
Name
직원
7
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TRAW's Discussions on Twitter

TRAW을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TRAW
Traws Pharma Inc
1.45 7.36M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
509.50 126.59B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
598.76 64.27B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
645.14 36.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
263.24 31.32B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
104.15 27.60B 2.98B -717.57M -264.74M -2.9987

Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-03-01 개시 Ladenburg Thalmann Buy
2021-05-18 개시 Guggenheim Buy
2018-03-01 재확인 H.C. Wainwright Buy
2018-01-17 다운그레이드 Maxim Group Buy → Hold
2017-10-09 개시 H.C. Wainwright Buy
2017-04-27 개시 Laidlaw Buy
2015-07-01 업그레이드 Piper Jaffray Neutral → Overweight
2015-05-05 개시 H.C. Wainwright Buy
모두보기

Traws Pharma Inc 주식(TRAW)의 최신 뉴스

pulisher
Apr 23, 2025

TRAW stock touches 52-week low at $1.51 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

TRAW stock touches 52-week low at $1.51 amid sharp annual decline - Investing.com India

Apr 23, 2025
pulisher
Apr 19, 2025

Traws Pharma Appoints New Chairman Amid Leadership Changes - MSN

Apr 19, 2025
pulisher
Apr 18, 2025

Traws Pharma appoints new interim CEO with compensation details By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 18, 2025

Traws Pharma appoints new interim CEO with compensation details - Investing.com Australia

Apr 18, 2025
pulisher
Apr 08, 2025

Traws Pharma announces $50 million stock offering potential - Investing.com Australia

Apr 08, 2025
pulisher
Apr 07, 2025

Traws Pharma announces $50 million stock offering potential By Investing.com - Investing.com Canada

Apr 07, 2025
pulisher
Apr 07, 2025

Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment - MSN

Apr 07, 2025
pulisher
Apr 05, 2025

Traws Pharma Reports 2024 Financial Results and Advances Bird Flu and COVID Programs - MSN

Apr 05, 2025
pulisher
Apr 02, 2025

TRAW stock touches 52-week low at $2.01 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

TRAW stock touches 52-week low at $2.01 amid sharp annual decline - Investing.com India

Apr 02, 2025
pulisher
Apr 02, 2025

Traws Pharma CEO Werner Cautreels to retire - MSN

Apr 02, 2025
pulisher
Apr 01, 2025

Traws Pharma Reports 2024 Results and Strategic Progress - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Traws Pharma Showcases Promising COVID-19 Drug at ICAR Conference - MSN

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Traws Pharma Q1 2025 shows innovation boost By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Traws Pharma Q1 2025 shows innovation boost - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma Announces Virtual Investor Event to Showcase Innovative Treatments for Bird Flu and COVID-19 - MSN

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma Reports 2024 Financial Results and CEO Change - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma Reports Full Year 2024 Results and Business Highlights - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma's Bird Flu Drug Shows Promise Despite $166M Annual LossKey Updates - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma (TRAW) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Traws Pharma Announces CEO Transition as Werner Cautreels Retires - MSN

Mar 30, 2025
pulisher
Mar 28, 2025

Traws Pharma announces CEO retirement and interim successor By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Traws Pharma announces CEO retirement and interim successor - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Traws Pharma CEO Werner Cautreels Retires, Chair Iain Duke Succeeds on Interim Basis - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Traws Pharma Announces Management Updates - GlobeNewswire

Mar 28, 2025
pulisher
Mar 28, 2025

Leadership Shift at Traws Pharma: Chairman Steps Up as CEO Exits, Key Antiviral Programs Continue - Stock Titan

Mar 28, 2025
pulisher
Mar 28, 2025

Traws Pharma Reports Promising Preclinical Results for Bird Flu Treatment - MSN

Mar 28, 2025
pulisher
Mar 26, 2025

Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET - The Manila Times

Mar 26, 2025
pulisher
Mar 26, 2025

Traws Pharma to Host Investor Event on Bird Flu and COVID - GlobeNewswire

Mar 26, 2025
pulisher
Mar 25, 2025

Traws Pharma presents data on COVID-19 candidate ratutrelvir at ICAR - TipRanks

Mar 25, 2025
pulisher
Mar 25, 2025

Traws Pharma’s ratutrelvir shows promise in COVID-19 treatment By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

Traws Pharma’s ratutrelvir shows promise in COVID-19 treatment - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Traws Pharma's COVID-19 Candidate, Ratutrelvir, Presented at ICAR - The Manila Times

Mar 25, 2025
pulisher
Mar 25, 2025

Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

Breakthrough: Next-Gen COVID Drug Defeats 18 Variants Without Ritonavir Boost - Stock Titan

Mar 25, 2025
pulisher
Mar 24, 2025

Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Breakthrough: New Bird Flu Drug Achieves Remarkable 99.9% Viral Reduction in Latest Primate Tests - Stock Titan

Mar 24, 2025

Traws Pharma Inc (TRAW) 재무 분석

Traws Pharma Inc (TRAW)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.15
price up icon 1.73%
$72.00
price up icon 0.84%
$32.82
price up icon 0.34%
$24.12
price up icon 2.12%
biotechnology ONC
$259.81
price up icon 4.02%
$104.15
price up icon 0.14%
자본화:     |  볼륨(24시간):